Literature DB >> 34392310

Serum docosahexaenoic acid levels are associated with brain volumes in extremely preterm born infants.

Lisa M Hortensius1,2, William Hellström3, Karin Sävman3,4, Rolf A Heckemann5, Isabella M Björkman-Burtscher6, Floris Groenendaal1,2, Mats X Andersson7, Anders K Nilsson8, Maria Luisa Tataranno1,2, Ruurd M van Elburg1,9, Ann Hellström8, Manon J N L Benders10,11.   

Abstract

BACKGROUND: Docosahexaenoic acid (DHA) and arachidonic acid (AA) are important for fetal brain growth and development. Our aim was to evaluate the association between serum DHA and AA levels and brain volumes in extremely preterm infants.
METHODS: Infants born at <28 weeks gestational age in 2013-2015, a cohort derived from a randomized controlled trial comparing two types of parenteral lipid emulsions, were included (n = 90). Serum DHA and AA levels were measured at postnatal days 1, 7, 14, and 28, and the area under the curve was calculated. Magnetic resonance (MR) imaging was performed at term-equivalent age (n = 66), and volumes of six brain regions were automatically generated.
RESULTS: After MR image quality assessment and area under the curve calculation, 48 infants were included (gestational age mean [SD] 25.5 [1.4] weeks). DHA levels were positively associated with total brain (B = 7.966, p = 0.012), cortical gray matter (B = 3.653, p = 0.036), deep gray matter (B = 0.439, p = 0.014), cerebellar (B = 0.932, p = 0.003), and white matter volume (B = 3.373, p = 0.022). AA levels showed no association with brain volumes.
CONCLUSIONS: Serum DHA levels during the first 28 postnatal days were positively associated with volumes of several brain structures in extremely preterm infants at term-equivalent age. IMPACT: Higher serum levels of DHA in the first 28 postnatal days are positively associated with brain volumes at term-equivalent age in extremely preterm born infants. Especially the most immature infants suffer from low DHA levels in the first 28 postnatal days, with little increase over time. Future research is needed to explore whether postnatal fatty acid supplementation can improve brain development and may serve as a nutritional preventive and therapeutic treatment option in extremely preterm infants.
© 2021. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34392310     DOI: 10.1038/s41390-021-01645-w

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  2 in total

Review 1.  Longchain polyunsaturated fatty acid supplementation in preterm infants.

Authors:  Kwi Moon; Shripada C Rao; Sven M Schulzke; Sanjay K Patole; Karen Simmer
Journal:  Cochrane Database Syst Rev       Date:  2016-12-20

2.  Should formula for infants provide arachidonic acid along with DHA? A position paper of the European Academy of Paediatrics and the Child Health Foundation.

Authors:  Berthold Koletzko; Karin Bergmann; J Thomas Brenna; Philip C Calder; Cristina Campoy; M Tom Clandinin; John Colombo; Mandy Daly; Tamás Decsi; Hans Demmelmair; Magnus Domellöf; Nataša FidlerMis; Ines Gonzalez-Casanova; Johannes B van Goudoever; Adamos Hadjipanayis; Olle Hernell; Alexandre Lapillonne; Silke Mader; Camilia R Martin; Valerie Matthäus; Usha Ramakrishan; Cornelius M Smuts; Sean J J Strain; Conny Tanjung; Patrick Tounian; Susan E Carlson
Journal:  Am J Clin Nutr       Date:  2020-01-01       Impact factor: 7.045

  2 in total
  1 in total

1.  Randomized controlled trial of early arachidonic acid and docosahexaenoic acid enteral supplementation in very preterm infants.

Authors:  Patricia Álvarez; David Ramiro-Cortijo; María Teresa Montes; Bárbara Moreno; María V Calvo; Ge Liu; Ana Esteban Romero; Marta Ybarra; Malaika Cordeiro; Marina Clambor Murube; Eva Valverde; Aurora Sánchez-Pacheco; Javier Fontecha; Robert Gibson; Miguel Saenz de Pipaon
Journal:  Front Pediatr       Date:  2022-08-25       Impact factor: 3.569

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.